PT77850B - Process for preparing new pharmacologically active pyrazolopyridines and of pharmaceutical compositions containing the same - Google Patents

Process for preparing new pharmacologically active pyrazolopyridines and of pharmaceutical compositions containing the same

Info

Publication number
PT77850B
PT77850B PT77850A PT7785083A PT77850B PT 77850 B PT77850 B PT 77850B PT 77850 A PT77850 A PT 77850A PT 7785083 A PT7785083 A PT 7785083A PT 77850 B PT77850 B PT 77850B
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
compositions containing
pyrazolopyridines
same
pharmacologically active
Prior art date
Application number
PT77850A
Other languages
English (en)
Portuguese (pt)
Other versions
PT77850A (en
Inventor
Giorgio Winters
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of PT77850A publication Critical patent/PT77850A/pt
Publication of PT77850B publication Critical patent/PT77850B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT77850A 1982-12-20 1983-12-19 Process for preparing new pharmacologically active pyrazolopyridines and of pharmaceutical compositions containing the same PT77850B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8236131 1982-12-20

Publications (2)

Publication Number Publication Date
PT77850A PT77850A (en) 1984-01-01
PT77850B true PT77850B (en) 1986-05-08

Family

ID=10535093

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77850A PT77850B (en) 1982-12-20 1983-12-19 Process for preparing new pharmacologically active pyrazolopyridines and of pharmaceutical compositions containing the same

Country Status (19)

Country Link
US (1) US4954508A (en, 2012)
EP (1) EP0114273B1 (en, 2012)
JP (1) JPH0660181B2 (en, 2012)
KR (1) KR890002227B1 (en, 2012)
AT (1) ATE69227T1 (en, 2012)
AU (1) AU574654B2 (en, 2012)
DE (1) DE3382452D1 (en, 2012)
DK (1) DK582083A (en, 2012)
ES (2) ES528152A0 (en, 2012)
FI (1) FI76337C (en, 2012)
GR (1) GR79111B (en, 2012)
IE (1) IE57305B1 (en, 2012)
IL (1) IL70445A (en, 2012)
MY (1) MY101250A (en, 2012)
NO (1) NO160367C (en, 2012)
NZ (1) NZ206626A (en, 2012)
PH (1) PH20896A (en, 2012)
PT (1) PT77850B (en, 2012)
ZA (1) ZA839092B (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔3,4−b〕ピリジン誘導体およびその製造法
JPS60197685A (ja) * 1984-03-19 1985-10-07 Shionogi & Co Ltd 4,7―ジヒドロピラゾロ[3,4―b]ピリジン誘導体とその製造法
US4873334A (en) * 1982-10-05 1989-10-10 Shionogi & Co., Ltd. 4,7-dihydropyrazolo(3,4-b) pyridine derivatives
JPS6056979A (ja) * 1983-09-08 1985-04-02 Shionogi & Co Ltd 4,7−ジヒドロピラゾロ〔3,4−b〕ピリジン誘導体およびその製造法
US4918074A (en) * 1984-03-12 1990-04-17 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocycle compounds
US4916140A (en) * 1988-09-28 1990-04-10 Merrell Dow Pharmaceuticals Inc. Antiepileptic pyrazolopyridines
US6977262B2 (en) 2001-02-02 2005-12-20 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
CA2437215A1 (en) * 2001-02-02 2002-08-15 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
KR20060070486A (ko) * 2003-06-13 2006-06-23 젠타리스 게엠베하 포스파티딜이노시톨 3-키나제의 억제 활성을 갖는 화합물및 이의 사용 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773778A (en) * 1972-01-24 1973-11-20 Squibb & Sons Inc Sulfur derivatives of pyrazolo (3,4-b)pyridines
DE2356684A1 (de) * 1972-11-15 1974-05-16 Heyden Chem Fab Neue 4-aminoderivate von pyrazolo (3,4-b)pyridin-5-carboxamiden
US4038283A (en) * 1975-04-30 1977-07-26 E. R. Squibb & Sons, Inc. 4-Alkoxy or hydroxy derivatives of 2H-pyrazolo[3,4-b]pyridine-5-carboxylic acids and esters
GB1568399A (en) * 1975-10-16 1980-05-29 Squibb & Sons Inc Pyrazolo pyridine derivatives
US4020072A (en) * 1976-05-04 1977-04-26 E. R. Squibb & Sons, Inc. 5-Aminomethyl-1H-pyrazolo[3,4-b]pyridines
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔3,4−b〕ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
MY101250A (en) 1991-08-17
NO160367C (no) 1989-04-12
ES8601987A1 (es) 1985-11-16
ES528152A0 (es) 1985-11-16
EP0114273B1 (en) 1991-11-06
FI76337C (fi) 1988-10-10
ZA839092B (en) 1984-07-25
IE57305B1 (en) 1992-07-15
IL70445A (en) 1988-12-30
JPH0660181B2 (ja) 1994-08-10
ATE69227T1 (de) 1991-11-15
NO834695L (no) 1984-06-21
PT77850A (en) 1984-01-01
DK582083D0 (da) 1983-12-16
FI76337B (fi) 1988-06-30
ES8506016A1 (es) 1985-06-16
NO160367B (no) 1989-01-02
AU2227083A (en) 1984-06-28
FI834661A0 (fi) 1983-12-19
KR890002227B1 (ko) 1989-06-24
KR840007000A (ko) 1984-12-04
US4954508A (en) 1990-09-04
AU574654B2 (en) 1988-07-14
GR79111B (en, 2012) 1984-10-02
ES532124A0 (es) 1985-06-16
FI834661A7 (fi) 1984-06-21
DE3382452D1 (de) 1991-12-12
EP0114273A1 (en) 1984-08-01
IE832988L (en) 1984-06-20
IL70445A0 (en) 1984-03-30
NZ206626A (en) 1986-11-12
DK582083A (da) 1984-06-21
PH20896A (en) 1987-05-27
JPS59118786A (ja) 1984-07-09

Similar Documents

Publication Publication Date Title
ES8603477A1 (es) Procedimiento para preparar una 1h-imidazo (4, 5-c) quinolin-4-amina
NZ214611A (en) Piperazine derivatives and pharmaceutical compositions
ES8307806A1 (es) "procedimiento para la preparacion de 1,2-a piridinas y pirazinas".
HUT53359A (en) Process for producing pharmaceutical compositions comprising oxooxazolinidyl cyclopentano benzene derivatives as active ingredient
HUT46657A (en) Process for producing antitumour pharmaceutical compositions comprising sulfonyl-urea derivatives as active ingredient
IL72354A0 (en) Imidazolium salts,processes for the preparation thereof and pharmaceutical compositions containing the same
HUT49494A (en) Process for producing active component of pharmaceutical compositions
ES8503685A1 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
PT77850B (en) Process for preparing new pharmacologically active pyrazolopyridines and of pharmaceutical compositions containing the same
ES8201580A1 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
HUT38344A (en) Process for preparing pyrazolo/3,4-b/pyridine amides
PT81954A (en) Process for the preparation of pharmaceutical compositions containing 9,10-dihydro alkalloids of ergot
IL75874A0 (en) Naphthyl analogs of mevalonolactone and derivatives thereof,their production and pharmaceutical compositions containing them
HUT39451A (en) Process for producing 6-substituted mitomycin derivatives and pharmaceutical compositions containing them as active agents
HUT47558A (en) Process for production of 12-halogene-forscoline derivatives and medical compositions containing them as active substance
ES8605518A1 (es) Procedimiento para preparar derivados de 4-oxo-pirido(2,3-d)pirimidina
HUT47569A (en) Process for production of derivatives of perhydrotiazepin and perhydroazepin and medical compositions containing them as active substance
HUT47579A (en) Process for production of new imidazo /1,2-a/-pirimidins and their salts and medical compositions containing them as active substance
HUT47023A (en) Process for production of medical compositions containing as active substance colesteril-phosphorilcolin-steroid
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.
HUT34158A (en) Process for preparing 2-alkyl-mercapto-1-amino-alkyl-2-pyrroline-3-carbonitriles
HUT47021A (en) Process for production of helping the heart action medical compositions containing as active substance 5-benzoil-tiazolon-derivatives

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19941130